Skip to content
Screener

Madrigal Pharmaceuticals, Inc. MDGL Business Segments — Labor and Related Expense

Similar metrics at other companies

Camden Property Trust logo
CPTReportable Segment — Labor and Related Expense
$26.35M+2.2%
Tradeweb Markets Inc. logo
TWReportable Segment — Labor and Related Expense
$172.46M+1.6%
Arvinas logo
ARVNReportable Segment — Labor and Related Expense
$21.3M-42.3%
Toast logo
TOSTReportable Segment — Labor and Related Expense
$58M-9.4%
SIT
SITEReportable Segment — Labor and Related Expense
$215.3M+6.0%
Option Care Health, Inc. logo
OPCHReportable Segment — Labor and Related Expense
$213.63M+0.7%

Other financials

Income statement

See full
Revenue$364.3M+71.2%
Gross profit$43.5M
Operating income-$56.3M-19.3%
Net income-$57.9M-37.0%
EPS (diluted)-$1.99-4.7%

Balance sheet

See full
Cash & equivalents$292.9M+53.2%
Total debt$377.9M+179%
Total equity$523.7M-24.7%
Total assets$1.2B+22.6%

Cash flow

See full
Operating cash flow-$167.4M-88.4%
CapEx$4.3M
Free cash flow-$171.3M-92.7%

Valuation

See full
Market cap$11.88B+57.6%
Enterprise value$11.96B+59.9%
P/S9.3×-5.4×

Profitability

See full
Gross margin96.5%
Operating margin-25.1%-9.2pp
Net margin-25.3%-8.8pp
FCF margin-59.8%-29.6pp

Returns & leverage

See full
Return on equity-53.3%+47.0pp
Debt / equity0.7×+0.5×
Current ratio3.2×-1.9×

Where this comes from

Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LaborAndRelatedExpense.

The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.

Filed
Jul 30, 2026, 9:06 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-050845
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Professional fees and other external expenses(67,841)(38,602)(152,388)(67,399)
Facility related and other internal expenses(1)(1,486)(1,656)(2,669)(2,781)
Selling, general and administrative:
Compensation and benefit-related expenses(80,321)(52,504)(163,926)(100,865)
Stock-based compensation(28,382)(19,805)(54,439)(35,521)
Professional fees and other external expenses(148,996)(109,841)(280,248)(197,855)
Facility related and other internal expenses(1)(31,676)(14,708)(59,283)(30,493)
Other segment (expense) income(2)(1,631)4,921(3,299)10,994

Item 1. Financial Statements (Unaudited):

FAQ

What is Madrigal Pharmaceuticals, Inc.'s business segments — labor and related expense?
Madrigal Pharmaceuticals, Inc. (MDGL) reported business segments — labor and related expense of $80.32M in Q2 2026.
What does business segments — labor and related expense mean?
This captures the total compensation costs, including salaries, benefits, and payroll taxes, for employees directly associated with the segment's operations. It reflects the human capital investment required to support commercial and research activities.

Ask your AI about Madrigal Pharmaceuticals, Inc.'s business segments — labor and related expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude